Horizon Therapeutics Public Ltd Co Inventory Write-down
Horizon Therapeutics Public Ltd Co reported Inventory Write-down of $83.00 thousand for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2018-11-07
- Horizon Therapeutics Public Ltd Co inventory write-down for the quarter ending 2018-09-30 was $83.00K, a 99.61% decline year-over-year.
- Horizon Therapeutics Public Ltd Co inventory write-down for the quarter ending 2018-06-30 was $53.00K, a 99.84% decline year-over-year.
- Horizon Therapeutics Public Ltd Co inventory write-down for the quarter ending 2017-09-30 was $21.17M.
- Horizon Therapeutics Public Ltd Co inventory write-down for the quarter ending 2017-06-30 was $33.90M.
| Period end | Inventory Write-down 3 month | Inventory Write-down 6 month | Inventory Write-down 9 month |
|---|---|---|---|
| 2018-09-30 | $83.00K 10-Q · filed 2018-11-07 | $136.00K derived: sum of 2 quarters · filed 2018-11-07 | $17.21M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $53.00K 10-Q · filed 2018-08-08 | $17.13M 10-Q · filed 2018-08-08 | |
| 2017-09-30 | $21.17M 10-Q · filed 2018-11-07 | $55.06M derived: sum of 2 quarters · filed 2018-11-07 | $95.66M 10-Q · filed 2018-11-07 |
| 2017-06-30 | $33.90M 10-Q · filed 2018-08-08 | $74.49M 10-Q · filed 2018-08-08 |